|
|
Dan M. Roden, Prakash C. Viswanathan
J Clin Invest. 2005;
115(8):2025
doi:10.1172/JCI25539
Abstract |
Full text
| PDF
T
he QT interval is the electrocardiographic manifestation of ventricular repolarization, is variable under physiologic conditions, and is measurably prolonged by many drugs. Rarely, however, individuals with normal base-line intervals may display exaggerated QT interval prolongation, and the potentially fatal polymorphic ventricular tachycardia torsade de pointes, with drugs or other environmental stressors such as heart block or heart failure. This review summarizes the molecular and cellular mechanisms underlying this acquired or drug-induced form of long QT syndrome, describes approaches to the analysis of a role for DNA variants in the mediation of individual susceptibility, and proposes that these concepts may be generalizable to common acquired arrhythmias.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(15)
| Title and authors |
Publication |
Year |
Potassium-channel mutations and cardiac arrhythmias—diagnosis and therapy
John R. Giudicessi, Michael J. Ackerman
|
Nat Rev Cardiol
|
2012 |
Peripartum Cardiomyopathy Presenting with Syncope due to Torsades de Pointes: a Case of Long QT Syndrome with a Novel KCNH2 Mutation
Orie Nishimoto, Morihiro Matsuda, Kei Nakamoto, Hirohiko Nishiyama, Kazuya Kuraoka, Kiyomi Taniyama, Ritsu Tamura, Wataru Shimizu, Toshiharu Kawamoto
|
Intern. Med.
|
2012 |
Coexisting mutations/polymorphisms of the long QT syndrome genes in patients with repaired Tetralogy of Fallot are associated with the risks of life-threatening events
Shuenn-Nan Chiu, Mei-Hwan Wu, Ming-Jai Su, Jou-Kou Wang, Ming-Tai Lin, Chien-Chih Chang, Hui-Wen Hsu, Ching-Tsuen Shen, Olivier Thériault, Mohamed Chahine
|
Hum Genet
|
2012 |
Torsades de pointes during laparoscopic adrenalectomy of a pheochromocytoma: a case report
Kinge van der Heide, Ann de Haes, Götz JK Wietasch, Ans CP Wiesfeld, Herman GD Hendriks
|
J Med Case Reports
|
2011 |
Refining repolarization reserve
Dan M. Roden, Robert L. Abraham
|
Heart Rhythm
|
2011 |
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
|
Journal of the American College of Cardiology
|
2010 |
Torsades: adjacent and triggering electrocardiographic events
Rory Childers
|
Journal of Electrocardiology
|
2010 |
Place et rôle de la pharmacologie de sécurité dans le développement des médicaments
J.-M. Guillon
|
Annales Pharmaceutiques Françaises
|
2010 |
Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology
Clemens Möller
|
Expert Rev. Clin. Pharmacol.
|
2010 |
SCN5A mutation associated with acute myocardial infarction.
Antonio Oliva, Dan Hu, Sami Viskin, Tabitha Carrier, Jonathan M Cordeiro, Hector Barajas-Martinez, Yusheng Wu, Elena Burashnikov, Ramon Brugada, Rafael Rosso, Alexandra Guerchicoff, Guido Pollevick, Vincenzo L Pascali, Charlie Antzelevitch
|
Leg Med (Tokyo)
|
2009 |
|